Braster® In-home Breast Exam to Soon Arrive in U.S. Market

Braster® CEO to present on the new system at upcoming Telehealth 2.0 Conference

Warsaw, Poland – The Braster® system, a new pain-free, radiation-free method to detect breast abnormalities earlier than exams performed by touch, will kick off its entry into the U.S. market at the upcoming Telehealth 2.0 conference in Orlando, FL, where CEO Marcin Halicki will present the new system to attendees. The Braster system uses a combination of imaging and AI algorithms to analyze subtle thermal changes occurring in the breast that may indicate the formation of a tumor. Halicki’s presentation, “m-Health Innovative Technology for In-Home Breast Self-Examination,” will be held on Sunday, April 23, at 12:45 p.m. ET at booth no. 1241. Attendees will also have an opportunity to learn more about the innovative system from Braster experts located at booth no. 1435.

Improving early detection for in-home breast exams

Early detection of tumors located in the breast is critical for overall treatment. Tumors located in the breasts can form at a rapid pace, sometimes developing in the time between regular ultrasound and mammography examinations.

The Braster system was created to help women, regardless of age, detect breast abnormalities early in development. Its technology is able to register subtle changes undetectable to the touch, and can identify growths as small as 3 mm, more than three times smaller than what typical breast self-exam methods are able to detect. With the Braster system, women are also able to easily and accurately monitor their breast health on a monthly basis.

The Braster system

The Braster system is a pre-screening, in-home breast examination method which complements standard diagnostic methods and screening examinations. The system uses liquid crystal contact thermography, which images areas of elevated temperature in the breast through direct contact with the skin. The system uses a form of AI, employing sophisticated algorithms that interpret the images to identify subtle changes in the breast that could be an indication of an abnormality. The examination with the Braster system takes about 15 minutes to complete, is pain-free, radiation-free, and is easily usable in the comfort of one’s home. The Braster device, a component of the Braster system, operates in tandem with a mobile application compatible with most tablets or smartphones. The app walks users through the examination step by step and informs them about the availability of their individual results, easily accessible at www.braster.eu. The Braster device design was developed by Pezy Group, a Dutch company that also creates design solutions for leading global brands such as Philips, Samsonite and Unilever.

U.S. availability

The Braster system is currently in review with the FDA, with a ruling expected in the second half of 2017. The system has been granted a CE mark and is certified as a medical device class IIA.